BioTech is a forward-thinking academic journal published by MDPI, specializing in the dynamic fields of applied microbiology, biotechnology, biochemistry, bioengineering, and biomedical engineering. Established for promoting impactful research from 2021 to 2024, this journal aims to bridge the gap between laboratory findings and practical applications, serving as a vital resource for researchers, practitioners, and students alike. With its Open Access model, BioTech ensures that groundbreaking innovations are freely available to the global community, fostering collaboration and knowledge transfer across disciplines. In the 2023 rankings, BioTech holds a strong position in Q2 and Q3 quartiles across various categories, reflecting its commitment to high-quality research output. Being indexed in renowned databases, the journal enhances its visibility and reach, making it a preferred platform for sharing transformative ideas and discoveries in biotechnology and related domains. Set against the backdrop of Switzerland’s thriving research environment, BioTech is poised to become an essential resource in the rapidly evolving landscape of life sciences.

New Biotechnology, published by Elsevier, is a distinguished academic journal focused on the innovative realms of biotechnology and bioengineering. With an impact factor reflecting its strong presence in the field, this journal serves as a vital resource for researchers and professionals in the life sciences, offering insights into cutting-edge advancements and applications in biotechnology, molecular biology, and related disciplines. The journal's open access policy enhances its accessibility, allowing broad dissemination of knowledge and research findings. With a robust set of Scopus ranks placing it in the top tiers of its categories, including rank #36 in Biotechnology and #24 in Bioengineering, New Biotechnology represents a critical platform for scholars aiming to contribute to the ongoing dialogue in these rapidly evolving fields. Since its inception in 2008 and continuing through to 2024, the journal remains committed to fostering innovation and collaboration among scientists dedicated to advancing biotechnological applications, thereby significantly impacting medicine and industry.

Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.

BIOPROCESS AND BIOSYSTEMS ENGINEERING is a prestigious journal published by Springer, dedicated to advancing the field of bioengineering and biotechnology. Established in 1996, this influential journal provides a platform for disseminating high-quality research that covers a wide spectrum of topics related to bioprocessing, biosystems, and their applications in medicine and environmental engineering. With an impressive impact factor and ranking in the top quartile (Q2) across bioengineering, biotechnology, and miscellaneous medical fields, BIOPROCESS AND BIOSYSTEMS ENGINEERING stands out as a critical resource for researchers, professionals, and students. The journal is indexed in Scopus, reflecting its significant contribution to the scientific community, particularly with its robust percentile rankings (77th in Biotechnology and 70th in Bioengineering). Available in both print and electronic formats, this journal ensures accessible research for those pushing the boundaries of knowledge in bioprocessing and biosystems. As it continues to evolve, BIOPROCESS AND BIOSYSTEMS ENGINEERING encourages submissions that contribute to innovative research practices and applications, thereby fostering academic collaboration and advancement in this dynamic field.

BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, published by Taylor & Francis Inc, serves as a vital platform for advancing research in the fields of biochemistry, biotechnology, and related areas of medicine. With an ISSN of 1082-6068 and an E-ISSN of 1532-2297, this journal has established itself with a notable Q3 ranking in the 2023 categories of Biochemistry, Biotechnology, and Miscellaneous Medicine, reflecting its relevance and contribution to these disciplines. The journal encompasses a wide range of topics, providing crucial insights into preparative methods, innovative biotechnological applications, and their implications for various medical advancements. Although not open access, the journal's rich content is crucial for researchers and professionals aiming to stay abreast of the latest developments and methodologies in biochemistry and biotechnology. With an enduring commitment to excellence since its inception in 1996, the journal remains an essential resource for academics and practitioners dedicated to advancing scientific knowledge and practical applications.

Applied Biological Chemistry, published by SPRINGER SINGAPORE PTE LTD, is a premier open access journal that has been serving the biological sciences community since 2016. With an ISSN of 2468-0834 and E-ISSN of 2468-0842, this journal is committed to disseminating high-quality research in the fields of Biochemistry, Genetics, Molecular Biology, and Organic Chemistry. The journal holds a commendable position within the scientific community, ranking in the Q2 quartile for both Biochemistry and Organic Chemistry niches as of 2023. It aims to foster innovative research and facilitate discussions that propel the understanding of complex biochemical processes and molecular techniques. By providing open access to its contents, Applied Biological Chemistry ensures that valuable research is readily available to researchers, professionals, and students globally, encouraging collaboration and knowledge sharing in this rapidly evolving discipline. Its pivotal role in enhancing scientific communication in the Netherlands and beyond is further underscored by a steadily increasing impact in the academic arena.

BMC Biotechnology, a leading journal in the field of biotechnology, is published by BMC and has been a pivotal platform for open-access research since 2000. With a focus on the diverse areas of biotechnology, including biochemistry, genetics, and molecular biology, this journal holds a prestigious Q2 ranking in its category for 2023 and demonstrates a commendable percentile rank in the top 66th for its Scopus listings. Operating out of the United Kingdom and covering research from 2001 to 2024, BMC Biotechnology is committed to disseminating high-quality, rigorously peer-reviewed articles that foster advancements and innovations in the biotechnology landscape. Researchers, professionals, and students alike will benefit from the journal's rich content and dedicated commitment to enhancing scientific discourse within the realm of biotechnology.

The Electronic Journal of Biotechnology is a premier Open Access journal published by Pontificia Universidad Catolica de Valparaiso, Chile, dedicated to advancing the fields of applied microbiology and biotechnology. With its inception in 1998 and an unwavering commitment to sharing knowledge, the journal has garnered a respectable ranking within the Q3 quartile for both its biotechnology and applied microbiology categories as of 2023, reflecting its significance in the academic community. Researchers and professionals will find its editorial rigor complemented by a robust platform for disseminating innovative findings, fostering collaboration, and driving forward biotechnology discussions. Given its inclusive approach, having transitioned to Open Access in 2014, the journal ensures that research is accessible to a global audience, making it a valuable resource for students, academics, and industry practitioners alike. Through the publication of original research, reviews, and critical insights, the Electronic Journal of Biotechnology aims to bridge the gap between scientific discovery and practical application, ultimately contributing to advancements in health, agriculture, and environmental sustainability.

BIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.